Home / 4884.T : JPX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does 4884.T make money? Does 4884.T have pricing power? What's the Earnings Whisper? Will 4884.T profit more as the business scales? What is 4884.T's management track record? Is 4884.T's current price justified?

Kringle Pharma, Inc.

¥440 +$48.00 (+12.24%)

JPX · 15 Sep 2026 06:30 UTC

Previous Close

¥450

Day Range

¥435¥447

Year Range

¥287¥601

Market Cap

3.55B

AVG Volume

155.41K

Trailing/Forward PE

-3.97/1.54

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

Tokyo Stock Exchange

Revenue (JPY)

4884.T Revenue (JPY) by quarter
Period	Revenue (JPY)
26 Q3	287.15M
26 Q2	17.43M
26 Q1	18.57M
25 Q4	18.32M
25 Q3	17.96M
25 Q2	17.77M
25 Q1	18.16M
24 Q4	18.54M
24 Q3	18.46M
24 Q2	24.34M

Net Income (JPY)

4884.T Net Income (JPY) by quarter
Period	Net Income (JPY)
26 Q3	-115.08M
26 Q2	-314.75M
26 Q1	-201.85M
25 Q4	-176.77M
25 Q3	-226.99M
25 Q2	-299.81M
25 Q1	-212.68M
24 Q4	-238.03M
24 Q3	-152.2M
24 Q2	-196.73M

Operating Income (JPY)

4884.T Operating Income (JPY) by quarter
Period	Operating Income (JPY)
26 Q3	-118.67M
26 Q2	-315.37M
26 Q1	-199.91M
25 Q4	-170.94M
25 Q3	-226.58M
25 Q2	-299.74M
25 Q1	-212.19M
24 Q4	-238.16M
24 Q3	-212.98M
24 Q2	-198.15M

EBITDA (JPY)

4884.T EBITDA (JPY) by quarter
Period	EBITDA (JPY)
26 Q3	-118.67M
26 Q2	-315.37M
26 Q1	-201.48M
25 Q4	-170.94M
25 Q3	-226.58M
25 Q2	-299.43M
25 Q1	-212.19M
24 Q4	-238.16M
24 Q3	-151.83M
24 Q2	-198.15M

Cash Flows (JPY)

4884.T Cash Flows (JPY) by quarter
Period	Cash Flows (JPY)
26 Q3	0
26 Q2	0
26 Q1	0
25 Q4	-755.78M
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0

EPS (JPY)

4884.T EPS (JPY) by quarter
Period	EPS (JPY)
26 Q3	-13.73
26 Q2	-43.17
26 Q1	-28.2
25 Q4	-25.64
25 Q3	-33.2
25 Q2	-43.92
25 Q1	-31.23
24 Q4	-35
24 Q3	-22.96
24 Q2	-30.6

Expenses (JPY)

4884.T Expenses (JPY) by quarter
Period	Expenses (JPY)
26 Q3	335.44M
26 Q2	333.53M
26 Q1	347.48M
25 Q4	-566.52M
25 Q3	244.55M
25 Q2	317.51M
25 Q1	230.35M
24 Q4	899.7M
24 Q3	-62.08M
24 Q2	222.49M

Cash & Debt (JPY)

4884.T Cash & Debt (JPY) by quarter
Period	Cash & Debt (JPY)
26 Q3	1.7B
26 Q2	1.59B
26 Q1	1.51B
25 Q4	2.25B
25 Q3	1.63B
25 Q2	1.89B
25 Q1	2.1B
24 Q4	2.31B
24 Q3	2.46B
24 Q2	2.49B

Debt ratios

4884.T Debt ratios by quarter
Period	Debt ratios
26 Q3	2.1
26 Q2	1.74
26 Q1	1.68
25 Q4	2.47
25 Q3	1.67
25 Q2	2.09
25 Q1	2.63
24 Q4	3.06
24 Q3	3.12
24 Q2	2.65

Margins

4884.T Margins by quarter
Period	Margins
26 Q3	75.49%
26 Q2	100%
26 Q1	0%
25 Q4	0%
25 Q3	0%
25 Q2	100%
25 Q1	0%
24 Q4	0%
24 Q3	100%
24 Q2	0%

Return on Capital

4884.T Return on Capital by quarter
Period	Return on Capital
26 Q3	-9.19%
26 Q2	-33.21%
26 Q1	-16.53%
25 Q4	-13.5%
25 Q3	-16.35%
25 Q2	-18.64%
25 Q1	-11.2%
24 Q4	-11.3%
24 Q3	-6.5%
24 Q2	-8.47%

Shares Outstanding

4884.T Shares Outstanding by quarter
Period	Shares Outstanding
26 Q3	8.38M
26 Q2	7.29M
26 Q1	7.16M
25 Q4	6.89M
25 Q3	6.84M
25 Q2	6.83M
25 Q1	6.81M
24 Q4	6.8M
24 Q3	6.63M
24 Q2	6.43M

Book Value Per Share (JPY)

4884.T Book Value Per Share (JPY) by quarter
Period	Book Value Per Share (JPY)
26 Q3	149.38
26 Q2	130.01
26 Q1	170.57
25 Q4	189.9
25 Q3	203.1
25 Q2	235.69
25 Q1	278.88
24 Q4	309.81
24 Q3	353.11
24 Q2	361.22

Total Assets (JPY)

4884.T Total Assets (JPY) by quarter
Period	Total Assets (JPY)
26 Q3	2B
26 Q2	1.99B
26 Q1	1.99B
25 Q4	2.08B
25 Q3	2.11B
25 Q2	2.29B
25 Q1	2.54B
24 Q4	2.76B
24 Q3	2.94B
24 Q2	2.91B

Price to Sales

4884.T Price to Sales by quarter
Period	Price to Sales
Sep 26	45.39
Sep 26	42.87
Sep 26	42.87
Aug 26	45.69
Aug 26	43.37
Aug 26	40.85
Aug 26	35
Jul 26	32.68
Jul 26	31.97
Jul 26	32.58
Jul 26	33.49
Jul 26	34.19
Jun 26	31.34
Jun 26	30.56
Jun 26	29.87
Jun 26	32.92
May 26	38.74
May 26	43.17
May 26	43.37
May 26	45.44
May 26	46.72
Apr 26	49.09
Apr 26	47.9
Apr 26	44.45
Apr 26	50.37
Mar 26	37.71
Mar 26	36.18
Mar 26	37.9
Mar 26	39.62
Feb 26	37.71
Feb 26	36.66
Feb 26	37.42
Feb 26	35.52
Jan 26	37.33
Jan 26	38.57
Jan 26	40
Jan 26	38.95
Dec 25	37.14
Dec 25	35.77
Dec 25	36.62
Dec 25	35.68
Dec 25	37
Nov 25	39.36
Nov 25	39.45
Nov 25	40.4
Nov 25	40.11
Oct 25	41.15
Oct 25	42.47
Oct 25	42.38
Oct 25	43.51
Oct 25	42.38
Sep 25	43.7
Sep 25	45.48
Sep 25	45.76
Sep 25	46.51
Aug 25	45.76
Aug 25	45.57
Aug 25	46.51
Aug 25	46.14
Aug 25	46.79
Jul 25	47.91
Jul 25	54.09
Jul 25	79.45
Jul 25	76.74
Jun 25	72.89
Jun 25	76.58
Jun 25	87.37
Jun 25	73.58
May 25	75.38
May 25	72.04
May 25	77.52
May 25	69.21
May 25	69.55
Apr 25	70.41
Apr 25	75.29
Apr 25	68.87
Apr 25	67.41
Mar 25	76.13
Mar 25	74.69
Mar 25	69.17
Mar 25	66.02
Feb 25	65.94
Feb 25	64.92
Feb 25	68.74
Feb 25	85.14
Jan 25	91.09
Jan 25	89.81
Jan 25	101.54
Jan 25	89.22
Dec 24	74.18
Dec 24	69.87
Dec 24	67.78
Dec 24	72.05
Dec 24	69.79
Nov 24	71.21
Nov 24	70.71
Nov 24	65.69
Nov 24	67.69
Nov 24	68.87
Oct 24	65.1

Price to Book

4884.T Price to Book by quarter
Period	Price to Book
Sep 26	3.46
Sep 26	3.27
Sep 26	3.27
Aug 26	3.48
Aug 26	3.31
Aug 26	3.12
Aug 26	2.67
Jul 26	2.49
Jul 26	2.44
Jul 26	2.48
Jul 26	2.55
Jul 26	2.61
Jun 26	1.86
Jun 26	1.82
Jun 26	1.78
Jun 26	1.96
May 26	2.3
May 26	2.57
May 26	2.58
May 26	2.7
May 26	2.78
Apr 26	2.92
Apr 26	2.85
Apr 26	2.64
Apr 26	3
Mar 26	2.08
Mar 26	2
Mar 26	2.09
Mar 26	2.19
Feb 26	2.08
Feb 26	2.02
Feb 26	2.06
Feb 26	1.96
Jan 26	2.06
Jan 26	2.13
Jan 26	2.21
Jan 26	2.15
Dec 25	2.05
Dec 25	1.87
Dec 25	1.91
Dec 25	1.86
Dec 25	1.93
Nov 25	2.05
Nov 25	2.06
Nov 25	2.11
Nov 25	2.09
Oct 25	2.15
Oct 25	2.22
Oct 25	2.21
Oct 25	2.27
Oct 25	2.21
Sep 25	1.98
Sep 25	2.06
Sep 25	2.07
Sep 25	2.11
Aug 25	2.07
Aug 25	2.07
Aug 25	2.11
Aug 25	2.09
Aug 25	2.12
Jul 25	2.17
Jul 25	2.45
Jul 25	3.6
Jul 25	3.48
Jun 25	3.05
Jun 25	3.21
Jun 25	3.66
Jun 25	3.08
May 25	3.16
May 25	3.02
May 25	3.25
May 25	2.9
May 25	2.91
Apr 25	2.95
Apr 25	3.15
Apr 25	2.88
Apr 25	2.82
Mar 25	2.89
Mar 25	2.84
Mar 25	2.63
Mar 25	2.51
Feb 25	2.5
Feb 25	2.47
Feb 25	2.61
Feb 25	3.23
Jan 25	3.46
Jan 25	3.41
Jan 25	3.86
Jan 25	3.39
Dec 24	2.82
Dec 24	2.36
Dec 24	2.29
Dec 24	2.44
Dec 24	2.36
Nov 24	2.41
Nov 24	2.39
Nov 24	2.22
Nov 24	2.29
Nov 24	2.33
Oct 24	2.2

No video analysis for this stock yet. Request one from our team.

AI Analysis

Kringle Pharma, Inc.

Video analysis: 4884.T

Similar companies